BioMarin Pharmaceutical
BMRN
#1437
Rank
C$17.12 B
Marketcap
$89.84
Share price
1.28%
Change (1 day)
-25.62%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): C$0.53 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are C$2.75 Billion. In 2023 the company made an earning of C$0.26 Billion, an increase over its 2022 earnings that were of C$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.53 B101.48%
2023 C$0.26 B26.07%
2022 C$0.20 B-298.51%
2021 -C$0.11 Billion78.04%
2020 -C$59.17 Million-55.36%
2019 -C$0.14 Billion-33.56%
2018 -C$0.2 Billion297.78%
2017 -C$50.16 Million-95.68%
2016 -C$1.17 Billion437.12%
2015 -C$0.22 Billion23.91%
2014 -C$0.18 Billion-29.25%
2013 -C$0.25 Billion49.23%
2012 -C$0.17 Billion171.11%
2011 -C$61 Million103.01%
2010 -C$30.05 Million-3903.54%
2009 C$0.78 M-98.31%
2008 C$46.72 M-189.7%
2007 -C$52.1 Million51.02%
2006 -C$34.5 Million-61.58%
2005 -C$89.78 Million-56.59%
2004 -C$0.21 Billion95.13%
2003 -C$0.11 Billion12.09%
2002 -C$94.54 Million73.19%
2001 -C$54.59 Million18.32%
2000 -C$46.14 Million19.65%
1999 -C$38.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.73 Billion-232.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.29 Billion-152.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$56.9 Million-110.40%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.35 B 1,792.41%๐Ÿ‡ซ๐Ÿ‡ท France
-C$0.14 Billion-125.51%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.13 B-76.10%๐Ÿ‡บ๐Ÿ‡ธ USA